PreprintAll rights reservedbioRxiv
NanoPro - a Framework for Probiotically-Guided Nanovector Therapy
Related
- Receptor-guided phage cocktails constrain Acinetobacter baumannii resistance and improve therapy
- Gefitinib-based therapy in refractory hepatocellular carcinoma with EGFR overexpression: a spatial profiling-guided case report
- Receptor-guided engineering of oncolytic vaccinia creates a synthetic support niche for off-the-shelf NK cell therapy
- The evolving immune ecosystem of TKI resistance in EGFR-mutant NSCLC: from treatment-induced remodeling to mechanism-guided therapy
- Mapping neutrophil membrane bioactivity to therapeutic interfaces: Biology, disease targeting, and activity-guided biomimetic therapy.
BibTeX
@misc{michels2026nanopro,
title = {{NanoPro - a Framework for Probiotically-Guided Nanovector Therapy}},
author = {Alexander Michels and Azra Haseki and Myra Ashraf and Audrey Lam and Kailyn R. Grant and Amy Lu and Rosa L. Vincent and Jongwon Im and Zakary S. Singer and Edward R. Ballister and Tal Danino},
howpublished = {bioRxiv},
year = {2026},
month = oct,
doi = {10.64898/2026.10.28.762486},
url = {https://www.biorxiv.org/content/10.64898/2026.10.28.762486v1},
}
RIS
TY - UNPB
TI - NanoPro - a Framework for Probiotically-Guided Nanovector Therapy
AU - Alexander Michels
AU - Azra Haseki
AU - Myra Ashraf
AU - Audrey Lam
AU - Kailyn R. Grant
AU - Amy Lu
AU - Rosa L. Vincent
AU - Jongwon Im
AU - Zakary S. Singer
AU - Edward R. Ballister
AU - Tal Danino
PY - 2026
DA - 2026/10/28
PB - bioRxiv
DO - 10.64898/2026.10.28.762486
UR - https://www.biorxiv.org/content/10.64898/2026.10.28.762486v1
SN - 2692-8205
ER -